Evaluating the relationship between alcohol consumption, tobacco use, and cardiovascular disease: A multivariable Mendelian randomization study
- PMID: 33275596
- PMCID: PMC7717538
- DOI: 10.1371/journal.pmed.1003410
Evaluating the relationship between alcohol consumption, tobacco use, and cardiovascular disease: A multivariable Mendelian randomization study
Abstract
Background: Alcohol consumption and smoking, 2 major risk factors for cardiovascular disease (CVD), often occur together. The objective of this study is to use a wide range of CVD risk factors and outcomes to evaluate potential total and direct causal roles of alcohol and tobacco use on CVD risk factors and events.
Methods and findings: Using large publicly available genome-wide association studies (GWASs) (results from more than 1.2 million combined study participants) of predominantly European ancestry, we conducted 2-sample single-variable Mendelian randomization (SVMR) and multivariable Mendelian randomization (MVMR) to simultaneously assess the independent impact of alcohol consumption and smoking on a wide range of CVD risk factors and outcomes. Multiple sensitivity analyses, including complementary Mendelian randomization (MR) methods, and secondary alcohol consumption and smoking datasets were used. SVMR showed genetic predisposition for alcohol consumption to be associated with CVD risk factors, including high-density lipoprotein cholesterol (HDL-C) (beta 0.40, 95% confidence interval (CI), 0.04-0.47, P value = 1.72 × 10-28), triglycerides (TRG) (beta -0.23, 95% CI, -0.30, -0.15, P value = 4.69 × 10-10), automated systolic blood pressure (BP) measurement (beta 0.11, 95% CI, 0.03-0.18, P value = 4.72 × 10-3), and automated diastolic BP measurement (beta 0.09, 95% CI, 0.03-0.16, P value = 5.24 × 10-3). Conversely, genetically predicted smoking was associated with increased TRG (beta 0.097, 95% CI, 0.014-0.027, P value = 6.59 × 10-12). Alcohol consumption was also associated with increased myocardial infarction (MI) and coronary heart disease (CHD) risks (MI odds ratio (OR) = 1.24, 95% CI, 1.03-1.50, P value = 0.02; CHD OR = 1.21, 95% CI, 1.01-1.45, P value = 0.04); however, its impact was attenuated in MVMR adjusting for smoking. Conversely, alcohol maintained an association with coronary atherosclerosis (OR 1.02, 95% CI, 1.01-1.03, P value = 5.56 × 10-4). In comparison, after adjusting for alcohol consumption, smoking retained its association with several CVD outcomes including MI (OR = 1.84, 95% CI, 1.43, 2.37, P value = 2.0 × 10-6), CHD (OR = 1.64, 95% CI, 1.28-2.09, P value = 8.07 × 10-5), heart failure (HF) (OR = 1.61, 95% CI, 1.32-1.95, P value = 1.9 × 10-6), and large artery atherosclerosis (OR = 2.4, 95% CI, 1.41-4.07, P value = 0.003). Notably, using the FinnGen cohort data, we were able to replicate the association between smoking and several CVD outcomes including MI (OR = 1.77, 95% CI, 1.10-2.84, P value = 0.02), HF (OR = 1.67, 95% CI, 1.14-2.46, P value = 0.008), and peripheral artery disease (PAD) (OR = 2.35, 95% CI, 1.38-4.01, P value = 0.002). The main limitations of this study include possible bias from unmeasured confounders, inability of summary-level MR to investigate a potentially nonlinear relationship between alcohol consumption and CVD risk, and the generalizability of the UK Biobank (UKB) to other populations.
Conclusions: Evaluating the widest range of CVD risk factors and outcomes of any alcohol consumption or smoking MR study to date, we failed to find a cardioprotective impact of genetically predicted alcohol consumption on CVD outcomes. However, alcohol was associated with and increased HDL-C, decreased TRG, and increased BP, which may indicate pathways through impact CVD risk, warranting further study. We found smoking to be a risk factor for many CVDs even after adjusting for alcohol. While future studies incorporating alcohol consumption patterns are necessary, our data suggest causal inference between alcohol, smoking, and CVD risk, further supporting that lifestyle modifications might be able to reduce overall CVD risk.
Conflict of interest statement
I have read the journal's policy and the authors of this manuscript have the following competing interests: GDS is an Academic Editor on PLOS Medicine’s Editorial Board. All other authors declare no potential conflicts of interest.
Figures
![Fig 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7717538/bin/pmed.1003410.g001.gif)
![Fig 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7717538/bin/pmed.1003410.g002.gif)
![Fig 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7717538/bin/pmed.1003410.g003.gif)
Similar articles
-
High-density lipoprotein functionality, cardiovascular health, and patterns of alcohol consumption: new insights and future perspectives.Curr Opin Lipidol. 2024 Feb 1;35(1):25-32. doi: 10.1097/MOL.0000000000000906. Epub 2023 Oct 3. Curr Opin Lipidol. 2024. PMID: 37788374 Review.
-
Causal associations between type 1 diabetes mellitus and cardiovascular diseases: a Mendelian randomization study.Cardiovasc Diabetol. 2023 Sep 2;22(1):236. doi: 10.1186/s12933-023-01974-6. Cardiovasc Diabetol. 2023. PMID: 37659996 Free PMC article.
-
Smoking, alcohol consumption, and 24 gastrointestinal diseases: Mendelian randomization analysis.Elife. 2023 Feb 2;12:e84051. doi: 10.7554/eLife.84051. Elife. 2023. PMID: 36727839 Free PMC article.
-
Smoking, alcohol consumption, and cancer: A mendelian randomisation study in UK Biobank and international genetic consortia participants.PLoS Med. 2020 Jul 23;17(7):e1003178. doi: 10.1371/journal.pmed.1003178. eCollection 2020 Jul. PLoS Med. 2020. PMID: 32701947 Free PMC article.
-
Associations of Smoking and Alcohol and Coffee Intake with Fracture and Bone Mineral Density: A Mendelian Randomization Study.Calcif Tissue Int. 2019 Dec;105(6):582-588. doi: 10.1007/s00223-019-00606-0. Epub 2019 Sep 4. Calcif Tissue Int. 2019. PMID: 31482193 Review.
Cited by
-
Alcohol Exposure and Disease Associations: A Mendelian Randomization and Meta-Analysis on Weekly Consumption and Problematic Drinking.Nutrients. 2024 May 17;16(10):1517. doi: 10.3390/nu16101517. Nutrients. 2024. PMID: 38794754 Free PMC article.
-
Biochemical, Hematological, Inflammatory, and Gut Permeability Biomarkers in Patients with Alcohol Withdrawal Syndrome with and without Delirium Tremens.J Clin Med. 2024 May 8;13(10):2776. doi: 10.3390/jcm13102776. J Clin Med. 2024. PMID: 38792318 Free PMC article.
-
Combining Transdiagnostic and Disorder-Level GWAS Enhances Precision of Psychiatric Genetic Risk Profiles in a Multi-Ancestry Sample.medRxiv [Preprint]. 2024 May 10:2024.05.09.24307111. doi: 10.1101/2024.05.09.24307111. medRxiv. 2024. PMID: 38766259 Free PMC article. Preprint.
-
Mendelian randomization study of whole blood viscosity and cardiovascular diseases.PLoS One. 2024 Apr 26;19(4):e0294095. doi: 10.1371/journal.pone.0294095. eCollection 2024. PLoS One. 2024. PMID: 38669241 Free PMC article.
-
Alcohol - a scoping review for Nordic Nutrition Recommendations 2023.Food Nutr Res. 2024 Apr 1;68. doi: 10.29219/fnr.v68.10540. eCollection 2024. Food Nutr Res. 2024. PMID: 38571916 Free PMC article. Review.
References
-
- World Health Organization. Global Progress Report on Implementation of the WHO Framework Convention on Tobacco Control. Geneva, Switzerland: World Health Organization; 2018. Available from: https://www.who.int/fctc/reporting/WHO-FCTC-2018_global_progress_report.pdf.
-
- World Health Organization. Global Status Report on Alcohol and Health. Geneva, Switzerland: World Health Organization; 2011. xii, p. 286.
-
- Ezzati M, Hoorn SV, Lopez AD, Danaei G, Rodgers A, Mathers CD, et al. Comparative Quantification of Mortality and Burden of Disease Attributable to Selected Risk Factors. In: Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL, editors. Global Burden of Disease and Risk Factors. Washington (DC): 2006. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous